Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Biotech
Cellectar lays off 60%, drops radiotherapy over new trial demand
Cellectar is halting work on its sole clinical-stage radiotherapy after receiving feedback from the FDA that a fresh study would be required.
James Waldron
Dec 11, 2024 5:40am
GE HealthCare to take over Japanese radiopharmaceutical venture
Dec 2, 2024 2:00pm
Novartis taps Ratio for $745M radiopharmaceutical pact
Nov 18, 2024 8:00am
Radiopharma Alpha-9 raises $175M series C to fund clinical push
Oct 23, 2024 9:15am
Sanofi returns to Orano with €300M for new radioligand 'pioneer'
Oct 17, 2024 5:20am
Pentixapharm scores $22M in IPO to advance radiopharma trials
Oct 3, 2024 10:36am
